<!DOCTYPE html>



<html>
<link rel="stylesheet" href="css/math.css" type="text/css" />

<style type="text/css">

      body {
        font-family: 'Ariel' 'Baskerville' 'Droid Serif';
        font-size: 24px;
        color: #2e2e2e;
		h1 {font-size:40px};

      }
      .gray {
      	background: #2e2e2e;
      	color: #FFFFFF;
      }
      
      .image {
      	background: #FFFFFF;
      	color: #000000;
		font-size: 18px;
		h1 {font-size:1px;}
      }
      
      .big{
      	font-size: 28px;
		h1 {font-size:40px};
      }
      
      .small {
      	font-size: 24px;
		
      }
	  
	  h1 {font-size:40px;}
	<!--
	code { color: navy; background-color: transparent; }
	div.codeblock { font-family: monospace;
		font-size: medium;
		color: navy; background-color: transparent;
		white-space: pre; }

	p.indent{ text-indent: 1cm; }
	table.support { margin: auto; }
	.support td, th { 
		font-family: sans-serif; font-size: small; }
	.support th { white-space: nowrap;  }
	.support thead th { text-align: left;  }
	table.support_legend { margin: auto; }
	.support_legend td { vertical-align: top; }
	.support_legend table th { 
		font-family: sans-serif; font-size: small; }
	table.browser_notes { margin: auto; }
	table.browser_notes td, th { vertical-align: top; }
	table.support td.perf { background-color: #99eeff; }
	table.support td.good { background-color: #aaff99; }
	table.support td.bad { background-color: #ff8888; }
	table.support td.ugly { background-color: silver; }
	table.support td.read { background-color: #ffffaa; }

	/*** Math formatting test commands ***/
	/***    fractions ***/
	table.fractionborder { margin: auto; 
		display: inline; vertical-align: -100%; }
	.fractionborder td.numerator{ border-bottom: thin black solid; }
	/***    fancy characters ***/
	i.hbar{ position: relative; }
	.hbar span{ position: absolute; left: 0; bottom: 0.65ex; }
	i.overstrike{ position: relative; }
	.overstrike span{ position: absolute; }
	.overstrike sup{ position: absolute; }
	.overstrike .up{ top: -0.2ex; left: 0; }
	.overstrike .hi{ bottom: 0.8ex; left: 0.5ex; }

	table.fraction-fallback { display: inline; }
	table.fraction-fallback { display: inline-table; }
	-->
</style>


  <head>
    <title>Sample Size Under the Additive Hazards Model</title>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
    <style type="text/css">
      /* Slideshow styles */
    </style>
  </head>
  <body>
    <textarea id="source">

class: center, middle, gray

# Sample Size Under the Additive Hazards Model 

#### Lee S. McDaniel

#### LSU Health New Orleans, School of Public Health

???
* Thank you for having me (Dr. Fang)
* Talking about clinical trials, esp. Non-inf
* Exploring sample size calculations when outcome is time to event
* Accomplished from additive hazards perspective

---
class: gray, big

# Non-inferiority Trials

* Test two active drugs <br><br>
* $C$ is old, bad side effects <br><br>
* $E$ is new, pleasant <br><br>
* Want to show similar probability of stroke
$$
H\_0: \pi\_{E} - \pi\_{C} \neq 0
$$
$$
H\_1: \pi\_{E} - \pi\_{C} = 0
$$

???

* Want pi to be LOW
* Old drug: side effects, cost, off patent

---

class: gray, big

# Non-inferiority Trials

 Nobody minds if the new drug is better
$$
H\_0: \pi\_{E} - \pi\_{C} \geq 0
$$
$$
H\_1: \pi\_{E} - \pi\_{C} < 0
$$

 But what if they really are equivalent?
 
 We need some slack
$$
H\_0: \pi\_{E} - \pi\_{C} \geq \delta
$$
$$
H\_1: \pi\_{E} - \pi\_{C} < \delta
$$

???

* If equivalent, CI would fail to reject H0

---


class: gray, big

# Additive vs. Proportional

$\lambda(t)$ = Event rate at time $t$ conditional on failure after $t$

Cox Proportional Hazards:
$$
\lambda\_i(t) = \lambda\_0(t)e^{\beta' \mathbf{Z}\_i(t)}
$$

Aalen's Additive Hazards:
$$
\lambda\_i(t) = \lambda\_0(t) + \gamma(t)' \mathbf{Z}\_i (t)
$$
???
Pros of Proportional:

- Proportional hazards is dominant
- Math is easy
- Nobody will fight you on it
- Intuitive *for statisticians*

Cons:

- Less intuitive for clinicians
- Risk of lightning fatality in males 4.6 times higher (huge difference! 50 fatalities)
- Prop haz doesn't correspond to any data generating mechanism
- add haz robust to model misspecification

---

class: gray, big

# Benefits of the Models
<div style="float:left;" width="200px">

 ### Proportional 
 
* Dominant
* No negative hazards
* Likelihood based
* Intuitive<br>
	*for statisticians*

</div>

<div style="float:right;" width="200px">

 ### Additive
 
* Don't need auxiliary<br> covariates
* Can be more  interpretable
* Intuitive<br>
	*for clinicians*
</div>

---

class: gray

# Motivation - SPORTIF III

* Non-inferiority trial with margin as <b>hazard difference</b> <br><br>
* Warfarin vs. ximelagatran <br><br>
* Exponential distribution assumed <br> <br>
* Low primary event rate (stroke, systemic embolic event, death), about 3% per year 



### What if endpoint had included bleeding?

* 35% per year event rate <br><br>
* Cannot appeal to exponentiality <br><br>
* (At least not if hazard rate is non-constant)

???

About Warfarin/downsides

- Warfarin used to prevent stroke after atrial fibrillation
- Invented in WI, because of dead cows
- Warfarin requires dose adjustment, ximelegatran would not
- Avoid spinach on Warfarin

About bleeding

- Bleeding is very common
- Minor bleeding may be giant bruises on arms
- Drug taken for decades

ximelegatran was abandoned due to liver toxicity

---

class: image

# Estimated Hazard

<center><img  width="525px"  src="LAASA/Figs/anybadhaz.png" /></center>

???

- Decreasing hazard function, definitely not constant.
- Estimated using muhaz package
- Kernel smoothing of Nelson-Aalen estimates

---

class: image

# Consequences of Analysis

<center><img  width="550px"  src="LAASA/Figs/errorsim.jpg" /></center>

???

- Only way to calculate sample size in a NI trial with additive margin is w/ parametric assumptions
- Analyzing using exponential assumption can cause major problems
- Reduced power, inflated type 1 error
- Both are unacceptable
- Shape parameter < 1 -> decreasing hazard
- Shape > 1 -> increasing hazard

---

class: center, middle, gray, big

<center><b>We want to design clinical trials based on a hazard difference without distributions.</b></center>

---

class: gray, big

# Additive Hazards

Aalen's original model
$$
\lambda\_i(t) = \lambda\_0(t) + \gamma(t)' \mathbf{Z}\_i (t)
$$

Lin and Ying model
$$
\lambda\_i(t) = \lambda\_0(t) + \gamma' \mathbf{Z}\_i (t)
$$

Treatment indicator: $Z_i = 1$

$$
\lambda_i (t) = \lambda\_0(t) + \gamma Z\_i
$$

So model reduces to

$$
\lambda\_{E}(t) - \lambda\_{C}(t) = \gamma
$$

???

- First we require the same effect size over time
- It may be useful to relax this
- Some treatments only kick in after months
- Remove possibility of switching treatment status
- lambda_A is hazard for control group


---


class: center, middle, gray, big

# Superiority Trials

---

class: gray, big

# Superiority - Setup
<b>Events are bad.</b>

We want to test
$$
\begin{aligned}
H\_0 : \lambda\_{E}(t) - \lambda\_{C}(t) = 0 \\\
H\_1 : \lambda\_{E}(t) - \lambda\_{C}(t) \\neq 0 
\end{aligned}
$$

Further define
<div style="position:relative; left:50px">

* $T$ = failure time
* $C$ = censoring time
* $X = \min(T,C)$
</div>

???

- Probably could actually be one-sided test, but that's not standard

---



class: gray

# Superiority Assumptions


<div style="position:relative; left:50px">


* Subjects are independent <br><br>
* $\lambda\_{E} (t) = \lambda\_{C}(t) + \gamma$ <br><br>
* Assignment to $E$ completely random w.p. <i>p</i> <br><br>
* Independent censoring <br><br>
* Censoring distribution common (surv. function = $G(t)$) <br><br>
* Local alternative:

$$
\lambda\_{E}^{(n)} (t) = \lambda\_{C}(t) + \gamma^{(n)}
$$
$$
\sqrt{n} \gamma^{(n)} \rightarrow \phi
$$
</div>

---



class: gray, big

<!--
# Superiority Test

From Lin and Ying model, estimating equation is
  
  
$$
\frac{ U(0) }{\sqrt{\widehat{\mbox{Var}}(U(0))}} = \frac{ \int { \left\\{ 1- \bar{Z}(t) \right\\} dM\_{E}(t)} -  \int { \bar{Z}(t) dM\_{C}(t)}}{\int \frac{ Y_A(t)Y_B(t)}{Y(t)} dN(t)} \xrightarrow{d} N(0,1)
$$

$$
U(\gamma) = \sum\_{i=1}^{n} \int\_{0}^{\infty} \\{ Z\_i - \bar{Z}(t)\\} \\{dN\_i(t) - Y\_i(t) \gamma Z\_i dt\\}
$$


<center><img style="width:350px" src="equations/superiorityeq.jpg" /></center>

where 

* <i>N<sub>i</sub></i>(<i>t</i>) = number of events to time <i>t</i> for subject <i>i</i>
* <i>n</i> = total number of subjects
* <i>Y<sub>i</sub></i>(<i>t</i>) = at-risk process for subject <i>i</i>
* <img style="width:175px; position:relative; top:22px" src="equations/zbar.jpg" />

Then to test under the null, use <i>U</i>(0).  Variance consistently estimated by


<center><img style="width:200px" src="equations/supvar.jpg" /></center>
-->



# Superiority Sample Size 

<!--
<div class="math" style="position:relative; top:200px">
	<i>n</i> = 
	<div class="fraction-inline">
		<span class="numerator">(<i>z</i><sub>&alpha;</sub> + <i>z</i><sub>&beta;</sub>)<sup>2</sup><i>d</i></span>
		<span class="divider">_________</span>
		<span class="denominator"><i>p</i>(1 &ndash; <i>p</i>)&gamma;<sup>2</sup>E(<i>X</i>)<sup>2</sup></span>
	</div>
</div>
-->
<div style="position:relative; top:150px">
$$ n = \frac{(z\_\alpha + z\_\beta)^2 d}{p(1-p)\gamma^2 E(X)^2}$$
</div>


???

- Minimized at p=1/2
- z's are normal quantiles
- prob of events is in numerator
- analogous to case of difference v. ratio of proportions
- longer followup time, lower sample size

---

class: center, middle, gray, big

# Non-Inferiority Trials

---




class: gray, big

# Non-inferiority Setup

Test:
$$
\begin{aligned}
H\_0 : \lambda\_{E} - \lambda\_{C} \geq \delta \\\
H\_1 : \lambda\_{E} - \lambda\_{C} < \delta
\end{aligned}
$$

Same assumptions as superiority

<center><b>Alternative is equivalence (not local)</b></center>

---



class: gray

# NI Sample Size
<!--
<div class="math" style="position:relative; top:200px">
	<i>n</i> = 
	<div class="fraction-inline">
		<span class="numerator">
		<i>z</i><sub>&beta;</sub><sup>2</sup><i>d</i> + <i>z</i><sub>&alpha;</sub><sup>2</sup>(<i>d</i> + &delta;E(<i>X</i>)(1 &ndash; 2<i>p</i>))
		 + 2<i>z</i><sub>&alpha;</sub><i>z</i><sub>&beta;</sub><span class="radic2">&radic;</span><span class="root"><i>d</i></span>
		<span class="radic2">&radic;</span><span class="root"><i>d</i> + &delta;E(<i>X</i>)(1 &ndash; 2<i>p</i>)</span>
				</span>
		<span class="divider">_________</span>
		<span class="denominator"><i>p</i>(1 &ndash; <i>p</i>)&delta;<sup>2</sup>E(<i>X</i>)<sup>2</sup></span>
	</div>
</div>
-->

<div style="position:relative; top:125px">
$$n = \frac{z\_\beta^2 d + z\_\alpha^2 \\left\\{ d + \delta E(X) (1-2p) \\right\\} + 2z\_\alpha z\_\beta \\sqrt{d} \\sqrt{d + \delta E(X)(1-2p)}}{p(1-p)\delta^2 E(X)^2}$$
</div>

---

class: gray, big

# Imaginary Sample Size

When is 
$$
d < \delta E(X) ?
$$

$d$ is small

$$
\begin{aligned}
d & \approx \int \lambda e^{-\lambda t} G(t) dt < \int \lambda e^{-\lambda t}dt \\\
& = 1-e^{-\lambda \tau} \approx \lambda \tau \approx \lambda E(X)
\end{aligned}
$$

So, (very) approximately,
$$
\lambda(t) < \delta
$$
---

class: gray, big

# Equal Allocation
<!--
<div class="math" style="position:relative; top:200px">
	<i>n</i> = 
	<div class="fraction-inline">
		<span class="numerator">(<i>z</i><sub>&alpha;</sub> + <i>z</i><sub>&beta;</sub>)<sup>2</sup><i>d</i></span>
		<span class="divider">_________</span>
		<span class="denominator"><i>p</i>(1 &ndash; <i>p</i>)&gamma;<sup>2</sup>E(<i>X</i>)<sup>2</sup></span>
	</div>
</div>
-->
<div style="position:relative; top:125px">
$$ n = \frac{(z\_\alpha + z\_\beta)^2 d}{p(1-p)\delta^2 E(X)^2}$$
</div>
---

class: image

# Simulations

<center><img  width="550px"  src="LAASA/Figs/powerNIc.png" /></center>

???

* n = 1000
* 10,000 replicates
* bars are 95% CIs
* target is 90% power

---

class: image

# Imbalance

<center><img  width="550px"  src="LAASA/Figs/imbalance.jpg" /></center>

???

- exponential hazards, all three valid
- log rank favors control
- add favors experimental
- exponential favors equal
- not a great way to decide
- as n increases, they coincide

---

class: gray, big

# Comparison to Logrank
<div style="position:relative; top:120px">
$$
n = \frac{(z\_\alpha + z\_\beta)^2 d}{p(1-p)\gamma^2 E(X)^2} \quad \mbox{vs.} \quad n = \frac{(z\_\alpha + z\_\beta)^2 }{p(1-p)d\log\Delta^2}
$$
</div>

???

- d leads to higher sample size in add, lower in prop
- prop doesn't depend on E(X)

---





<center>
<iframe style="width:750px; height:600px" src="samplesize.html" frameborder="0"></iframe>
</center>

---


# SPORTIF: Primary Endpoint

<div style="float:left; width:475px">
<img  width="475px"  src="LAASA/Figs/primaryhaz.png" />
</div>

<div style="float:right;" width="100px">
Exponential analysis: <br>
 reject inferiority for
$$\delta > 0.127\%$$
<br>
Additive analysis: <br>
 reject inferiority for
$$\delta > 0.132\%$$
<div>

???

- low event rate
- wide confidence intervals
- not much difference
- original margin was 2%

---

# SPORTIF: Any Bad Event

<div style="float:left; width:475px">
<img  width="475px"  src="LAASA/Figs/anybadhaz.png" />
</div>

<div style="float:right;" width="100px">
Exponential analysis: <br>
 reject inferiority for
$$\delta > -0.905\%$$
<br>
Additive analysis: <br>
 reject inferiority for
$$\delta > -0.585\%$$
<div>

???

- somewhat confusing interepretation
- 0.4% difference
- 20% of original margin

---



class: center, middle, gray, big

### Thank you!


    </textarea>
    <script src="js/remark-0.6.0.min.js" type="text/javascript">
    </script>
    <script type="text/javascript">
      var slideshow = remark.create();
    </script>
   <script type="text/x-mathjax-config">
MathJax.Hub.Config({
  tex2jax: {inlineMath: [['$','$'], ['\\(','\\)']]}
});
</script>
<script type="text/javascript"
  src="js/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>
<script>
for (var i=0; i<document.getElementsByClassName("remark-slide-number").length ;i++){
document.getElementsByClassName("remark-slide-number")[i].hidden = false;
document.getElementsByClassName("remark-slide-number")[i].style.fontSize = "24px";
}
</script>
  </body>
</html>